USANA Q2: net sales +11% to $236M, net earnings -7%; FY guidance reiterated

USANA HEALTH SCIENCES INC

2025-Q2 EPS reported $1.01 revenue$485,387,000

Net sales $236M (+11% YoY); net earnings $9.7M (-7% YoY); diluted EPS $0.52 (-4% YoY).
Adjusted diluted EPS $0.74 (+36% YoY); adjusted EBITDA $30.5M (+13% YoY).
Direct selling Active Customers fell 11% YoY to 418k; Hiya subscribers 200.4k.
Repurchased 528k shares for $15M; ended quarter debt-free with $151M cash.
Reiterated FY2025 outlook: net sales $920M-$1.0B, adjusted EPS $2.35-$3.00.

item 2.02item 7.01item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.